NeoPhore appoints Michael Shih as Chief Executive Officer
Highly experienced corporate development leader with a track record of international pharma and biotech deal-makingNew CEO to drive growth strategy to maximise...
Cancer
Best Legal Steroids: Effective Bodybuilding Steroid Alternatives for Muscle Growth
Closest thing to real steroids to use for cutting and bulking in the bodybuilding industry SAN FRANCISCO, CA / ACCESSWIRE...
Rakovina Therapeutics Announces Closing of Oversubscribed $3M Private Placement
VANCOUVER, British Columbia, Dec. 13, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company”, “Rakovina”, or “Rakovina Therapeutics”)...
Checkpoint Therapeutics Announces FDA Approval of UNLOXCYT™ (cosibelimab-ipdl)
UNLOXCYT is the first and only FDA-approved anti-PD-L1 treatment for advanced cutaneous squamous cell carcinomaWALTHAM, Mass., Dec. 13, 2024 (GLOBE...
BriaCell Therapeutics Announces Closing of $5.5 Million Public Offering
PHILADELPHIA and VANCOUVER, British Columbia, Dec. 13, 2024 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell”...
Patient Controlled Injectors Market Size Set for Explosive Growth, With Projections Indicating $ 12.33 billion by 2031 | The Insight Partners
The report from The Insight Partners lists several stakeholders—including healthcare providers, government agencies and health authorities, insurance providers, and academic...
Lumicell Announces Poster Presentations at the 2024 San Antonio Breast Cancer Symposium Focused on Patient Benefit of Using LumiSystem™ During Lumpectomy
New data suggests that patients were satisfied with their cosmetic outcomes following the removal of suspicious tissue detected by fluorescence-guided...
This Week in Health News: 15 Stories You Need to See
A roundup of the most newsworthy healthcare press releases from PR Newswire this week, including a survey on nicotine use...
Ladenburg Thalmann to Host Scientific Showcase December 18, 2024 About Rare Disease Clinical Development Efforts for Jaguar Health’s Crofelemer
Crofelemer is the subject of five clinical efforts - three proof-of-concept investigator-initiated trials (IIT) and two Phase 2 studies -...
Medicenna Presents Preclinical Data on MDNA11 as First Step to Shrink Tumors Before Surgery and Prevent Metastasis at the 2024 San Antonio Breast Cancer Symposium (SABCS)
Single-agent MDNA11 was more effective than a combination of immune checkpoint inhibitors (anti-mPD1 and anti-mCTLA4) in preventing metastasis and achieving...
Angle PLC Announces HER2 Presentation at SABCS
WEILL CORNELL MEDICINE PRESENTS HER2 PARSORTIX WORKFLOW AT SAN ANTONIO BREAST CANCER SYMPOSIUMIndependent findings support ANGLE's HER2 assay development programmePotential...
Health Union Earns 12 Digital Health Awards for Excellence in Patient Education and Support
Health Union earns Gold for "Patient Insider," its innovative patient influencer experience, as well as recognition for outstanding achievements in...
Aptevo Therapeutics Announces Exercise of Warrants for $6.2 Million Gross Proceeds
SEATTLE, WA / ACCESSWIRE / December 12, 2024 / Aptevo Therapeutics Inc. (NASDAQ:APVO) ("Aptevo" or the "Company"), a clinical-stage biotechnology...
Healthcare Executives Embrace Generative AI to Boost Patient Outcomes
Issued on behalf of Avant Technologies Inc. VANCOUVER, BC, Dec. 12, 2024 /PRNewswire/ -- USA News Group News Commentary – The...
New Lunit Study Demonstrates Universal AI Model for Analysis of Immunohistochemistry Images
Research in npj Precision Oncology highlights multi-cohort training approach and accurate analysis of unseen immunohistochemistry data SEOUL, South Korea, Dec....
Allied Digestive Health Partners with Adonis to Innovate Revenue Cycle Operations
ADH turns to Adonis to deliver AI enabled intelligence and alerts that drive superior RCM outcomes. NEW YORK, Dec. 12,...
Chung-Ang University Researchers Unveil the Biogenesis and Role of Transfer RNA Fragments in Cancer Progression
Study reveals that 5'-tRNAGly(GCC) is a key regulator of gene expression and a potential therapeutic target in cancer SEOUL, Dec....
XChange Place Launches Exclusive Investment Opportunity in Cutting-Edge Early Cancer Detection and Treatment TechBio Firm
Revolutionary Digital Marketplace for Alternative Investments Unveils Exclusive Limited-Time Offering to Accredited Investors TechBio Firm, Backed by World-Class Venture Capital...
VolitionRx Appoints LifeSci Advisors as Investor Relations Consultants
Volition to participate in the upcoming 14th Annual LifeSci Partners Corporate Access Event on January 15th, 2025 at the Beacon...
Novellia Data Shown to Optimize Risk Profiling to Inform HER2+ Breast Cancer Care
-- New research demonstrates integrating AI-enabled, health record data insights with targeted educational interventions can enhance understanding and management of...